Nuage Therapeutics was incorporated in 2021 with the mission to leverage chemical biology and biomolecular condensation to develop selective drugs targeting proteins with disordered regions for challenging indications, thus improving patients’ lives. The first program is for castration-resistant prostate cancer.
Image
